DUBLIN, September 27, 2017 /PRNewswire/ --
The "UK In-Vitro Diagnostics Market - Growth, Trends & Forecast 2017 - 2022" report has been added to Research and Markets' offering.
The UK's market for In-Vitro Diagnostics is currently estimated to be worth USD 3.70 billion in the year 2014 and is expected to reach USD 4.83 billion by the end of 2020. The CAGR during this period of the forecast is 5.47%.
Currently, North America dominates the global market, with the market yet to reach saturation. Europe is the second-largest market in the world for In-Vitro Diagnostics and is expected to continue this domination to a certain extent. This escalation is developing the need to analyze, review and forecast the growth of the In-Vitro Diagnostics market.
UK In-Vitro Diagnostics Market-Market Dynamics
The report details several factors driving and restraining the growth of the market. Some of these are discussed below.
Drivers
Some of the factors contributing to the growth of market are:
- Rapid increase in the chronic & infectious disease population
- Technological advances
- Rapidly aging population
- Advent of point of care diagnostics
- Restraints
Some of the factors limiting the growth of the market are a lack of proper reimbursement policies and stringent regulatory framework.
The report studies in detail the market for different In-Vitro Diagnostic techniques, which include clinical chemistry, hematology, immunoassays, point of care diagnostics, molecular diagnostics and coagulation. The products sector includes instruments, reagents, and data management systems. Molecular diagnostics currently dominate the global market and are expected to dominate it in the near future also.
Key Topics Covered:
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Threats
4. Porter's Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
6. Medical Devices Market - By Type
6.1 In - Vitro Diagnostics
6.1.1 By Technique
6.1.1.1 Clinical Chemistry
6.1.1.2 Immunoassays
6.1.1.3 Point of care diagnostics
6.1.1.4 Molecular Diagnostics
6.1.1.5 Hematology
6.1.1.6 Coagulation
6.1.1.7 Microbiology
6.1.2 By Type of product
6.1.2.1 Instruments
6.1.2.2 Reagents
6.1.2.3 Data Management Systems
6.1.3 By Usability
6.1.3.1 Disposable IVD Devices
6.1.3.2 Reusable IVD Devices
6.1.4 By Applications
6.1.4.1 Infectious diseases
6.1.4.2 Diabetes
6.1.4.3 Oncology
6.1.4.4 Cardiology
6.1.4.5 Auto Immune Diseases
6.1.4.6 Nephrology
6.1.4.7 Drug Testing
6.1.4.8 HIV/AIDS
6.1.4.9 Others
6.1.5 By End user
6.1.5.1 Laboratory
6.1.5.2 Academics
6.1.5.3 Hospitals
6.1.5.4 Point of Care testing
6.1.5.5 Others
6.1.6 By Geography
6.1.6.1 UK
7. Competitive Landscape
7.1 Mergers & Acquisitions
7.2 Agreements, Collaborations & Partnerships
7.3 New Product Launches
7.4 Recommendations to new market players
8. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/jnqcj2/uk_invitro
heMedia Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article